RecallRadar

FDA Drug recall D-0027-2015

Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), Rx only, Mfd. for SAG…

On 2014-10-22 the FDA classified a Class II recall of Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), Rx only, Mfd. for SAG… by Sagent Pharmaceuticals, citing incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0027-2015
ClassificationClass II
Statusterminated
Initiated2014-10-03
Published2014-10-22
Last updated2026-09-13 11:51 UTC
CompanySagent Pharmaceuticals
DistributionUS

Product

Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195

Reason

Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.

Identifiers

ndc25021-700-01
ndc25021-701-01
ndc25021-701-02
code_infoLot MP5021, Exp. 04/16; Lots MP5024, MP5025, Exp. 05/16

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0027-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.